HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,292,189 | +2.8% | 164,717 | -2.9% | 0.03% | +7.4% |
Q2 2023 | $6,120,863 | -9.3% | 169,694 | -3.9% | 0.03% | -6.9% |
Q1 2023 | $6,747,065 | -33.5% | 176,671 | -0.9% | 0.03% | -34.1% |
Q4 2022 | $10,140,377 | +42.2% | 178,214 | -1.2% | 0.04% | +33.3% |
Q3 2022 | $7,132,000 | -10.8% | 180,377 | -0.7% | 0.03% | -2.9% |
Q2 2022 | $7,996,000 | +8.5% | 181,724 | -1.6% | 0.03% | +25.9% |
Q1 2022 | $7,367,000 | -0.6% | 184,728 | +0.2% | 0.03% | +3.8% |
Q4 2021 | $7,413,000 | -1.1% | 184,356 | +0.0% | 0.03% | -7.1% |
Q3 2021 | $7,497,000 | -5.3% | 184,296 | +5.7% | 0.03% | -3.4% |
Q2 2021 | $7,918,000 | +14.4% | 174,366 | +5.1% | 0.03% | +11.5% |
Q1 2021 | $6,919,000 | -2.2% | 165,972 | +0.2% | 0.03% | -7.1% |
Q4 2020 | $7,074,000 | – | 165,634 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
2Xideas AG | 600,799 | $22,950,522 | 2.54% |
BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |